Biotech Announces ‘Late-Breaking’ Addition to Immunotherapy Conference – Streetwise Reports
Streetwise Reports |
Biotech Announces ‘Late-Breaking’ Addition to Immunotherapy Conference
Streetwise Reports An Oct. 12 research report noted that Infinity Pharmaceuticals Inc. (INFI:NASDAQ) announced “an IPI-549 late-breaking oral presentation” at the Society for Immunotherapy of Cancer’s (SITC’s) yearly conference next month.” The presentation will … |
Chicago Tribune |
How is editing DNA like working your way up the ladder? Adapting.
Chicago Tribune Sternberg’s work involves the CRISPR-Cas systems and their implications in genome engineering. “With CRISPR, we can … rewrite DNA inside of cells and organisms and rethink how life operates and how we can manipulate that life,” he said. This kind of … |